comparemela.com

Latest Breaking News On - Prostate carcinoma - Page 1 : comparemela.com

New Trials in Prostate Cancer: Could Your Patient Benefit?

Perhaps one of your patients could benefit from a clinical trial that has recently opened in prostate cancer.

South koreaUnited statesOchsner medical centerPuerto ricoRhode islandUnited kingdomLos angelesMarcb garnickNational cancer instituteHoag cancer center irvineHarvard medical schoolBeth israel deaconess medical centerMedical newsCancer instituteTower urologyCleveland clinic

Xlife Sciences AG Publishes 2023 Annual Report - adhoc - Börsennachrichten

Xlife Sciences AG Key word Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23Apr2024 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsibl

United statesAbu dhabiAbuz abyUnited arab emiratesSynimmune gmbOliverr baumannXlife groupEuropean patent officeAxenoll life sciencesLife sciences hubXlife sciencesDepartment of health abu dhabiBusiness developmentOperational progressSynimmune gmbhProstate carcinoma

Xlife Sciences AG Publishes 2023 Annual Report

Xlife Sciences AG / Key word: Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The.

Abu dhabiAbuz abyUnited arab emiratesUnited statesOliverr baumannSynimmune gmbEuropean patent officeXlife sciencesAxenoll life sciencesLife sciences hubBusiness developmentDepartment of health abu dhabiXlife groupOperational progressSynimmune gmbhProstate carcinoma

How Long Should Active Surveillance Last?

How Long Should Active Surveillance Last?
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United statesVastra gotalands lanSan franciscoEmmeli palmstedtMatthewr cooperbergUniversity of gothenburgSahlgrenska academyEuropean association of urologyDepartment of urologyUniversity of californiaEuropean associationFree survival fallsProstate carcinomaAlignant prostate neoplasmProstate cancerAncer of the prostate

New Screening Protocol May Improve Prostate Cancer Detection

However, it's not yet clear whether a new three-phase screening intervention, which incorporates PSA test, a four-kallikrein panel, and MRI, will reduce prostate cancer mortality.

United statesAnssi auvinenTampere universityFinnish proscreenProscreen trial investigatorsProstate carcinomaAlignant prostate neoplasmProstate cancerAncer of the prostateAlignant neoplasiaAlignant neoplasmBiologic therapyProstate specific antigenSa prostate specific antigenPreventive screening

vimarsana © 2020. All Rights Reserved.